Consistently, our results demonstrated that HERG1 is overall upregulated in hepatocellular carcinoma, bladder cancer, gastric cancer, and ovarian cancer, indicating that HERG1 upregulation is ubiquitous in various types of cancer. The gene discussed is KCNH2; the disease is urinary bladder cancer.